OA09908A - Treatment of neoplastic disease with interleukin-10 - Google Patents

Treatment of neoplastic disease with interleukin-10

Info

Publication number
OA09908A
OA09908A OA60389A OA60389A OA09908A OA 09908 A OA09908 A OA 09908A OA 60389 A OA60389 A OA 60389A OA 60389 A OA60389 A OA 60389A OA 09908 A OA09908 A OA 09908A
Authority
OA
OAPI
Prior art keywords
interleukin
treatment
neoplastic disease
patient
effective amount
Prior art date
Application number
OA60389A
Other languages
English (en)
Inventor
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA09908A publication Critical patent/OA09908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
OA60389A 1991-01-16 1993-07-07 Treatment of neoplastic disease with interleukin-10 OA09908A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64134791A 1991-01-16 1991-01-16

Publications (1)

Publication Number Publication Date
OA09908A true OA09908A (en) 1994-09-15

Family

ID=24571976

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60389A OA09908A (en) 1991-01-16 1993-07-07 Treatment of neoplastic disease with interleukin-10

Country Status (18)

Country Link
EP (1) EP0567576B1 (es)
JP (1) JP3260368B2 (es)
KR (1) KR100207766B1 (es)
AT (1) ATE116550T1 (es)
AU (1) AU652030B2 (es)
CA (1) CA2100553A1 (es)
CZ (1) CZ282523B6 (es)
DE (1) DE69201128T2 (es)
DK (1) DK0567576T3 (es)
ES (1) ES2068705T3 (es)
FI (1) FI933193L (es)
GR (1) GR3015510T3 (es)
HK (1) HK192196A (es)
HU (1) HU218598B (es)
NO (1) NO310444B1 (es)
OA (1) OA09908A (es)
SK (1) SK279556B6 (es)
WO (1) WO1992012725A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
DE4122402A1 (de) * 1991-07-04 1993-01-07 Schering Ag Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
WO1994004180A2 (en) * 1992-08-20 1994-03-03 Schering Corporation Novel uses of il-4 and/or il-10, and antibodies against the same
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
PL175343B1 (pl) * 1994-01-20 1998-12-31 Schering Corp Sposób pozaustrojowego wytwarzania aktywowanych jednojądrzastych komórek krwi obwodowej, kompozycja farmaceutyczna do pozaustrojowego wytwarzania aktywowanych jednojądrzastych komórek krwi obwodowej i kompozycja farmaceutyczna do leczenia nowotworów
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
EP1621206A1 (en) 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
AU5827000A (en) * 1999-07-16 2001-02-05 Maria Teresa Bejarano Viral il-10 uses
ATE516820T1 (de) 2000-09-29 2011-08-15 Schering Corp Pegyliertes interleukin 10
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
EP3348281B1 (en) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
HK1226308A1 (zh) 2013-08-30 2017-09-29 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
KR20170068553A (ko) 2014-10-14 2017-06-19 아르모 바이오사이언시스 인코포레이티드 인터류킨-15 조성물 및 이의 용도
JP6675394B2 (ja) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害の治療のためにインターロイキン−１０を使用する方法
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
DE69013011T2 (de) * 1989-12-20 1995-02-23 Schering Corp., Kenilworth, N.J. Bcrf1-proteine als inhibitoren von interferon-g(g).

Also Published As

Publication number Publication date
CZ282523B6 (cs) 1997-07-16
HUT69962A (en) 1995-09-28
GR3015510T3 (en) 1995-06-30
AU652030B2 (en) 1994-08-11
HU218598B (hu) 2000-10-28
JPH06504785A (ja) 1994-06-02
EP0567576B1 (en) 1995-01-04
FI933193A0 (fi) 1993-07-14
FI933193A7 (fi) 1993-07-14
CA2100553A1 (en) 1992-07-17
ES2068705T3 (es) 1995-04-16
DK0567576T3 (da) 1995-06-12
EP0567576A1 (en) 1993-11-03
WO1992012725A1 (en) 1992-08-06
AU1261792A (en) 1992-08-27
SK279556B6 (sk) 1998-12-02
NO932570L (no) 1993-07-15
FI933193L (fi) 1993-07-14
ATE116550T1 (de) 1995-01-15
HK192196A (en) 1996-10-25
CZ141293A3 (en) 1994-01-19
DE69201128D1 (de) 1995-02-16
JP3260368B2 (ja) 2002-02-25
NO310444B1 (no) 2001-07-09
NO932570D0 (no) 1993-07-15
SK74793A3 (en) 1995-03-08
HU9302066D0 (en) 1993-11-29
KR100207766B1 (ko) 1999-07-15
DE69201128T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
GR3015510T3 (en) Treatment of neoplastic disease with interleukin-10.
EG19304A (en) Method of treating pre-menstrual syndrome
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
ZA913282B (en) Dosage form
AU1808488A (en) Compounds for the treatment of alzheimer's disease
EP0102534A3 (en) Hair-growing agent
IE900250L (en) Immunogenic compositions against gastrin peptides
GR3029670T3 (en) Treatment of macular degeneration.
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
SG45366A1 (en) Method of treating and/or diagonising soft tissue tumors
ZA886459B (en) Use of bezafibrate for treating diabetes
MY104521A (en) Treatment of depression.
PH31582A (en) Glycoslated cytokins.
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
PL277464A1 (en) Apparatus for surgical treatment of ametropia
HU900381D0 (en) Process for producing medical preparatives utilizable for treating cancerous diseases
ES2005926A6 (es) Aparato de estimulacion de la piel mediante una senal electromagnetica.
HUT64478A (en) Process for producing medical preparatives for treatment of b-cell tumours
PL283664A1 (en) Therapeutical set for treating limb bone fractures by traction
IL68896A0 (en) Medicine for treatment of neoplastic diseases
IT1243947B (it) 2-azido-ornitina, sua preparazione e suo impiego in terapia
RU93046326A (ru) Способ лечения медикаментозных эзофаго-гингиво-стоматитов
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.